Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.

J Clin Oncol

Massimo Di Maio, Maria Carmela Piccirillo, Gennaro Daniele, Francesco Nuzzo, Andrea de Matteis, Jane Bryce, Alessandro Morabito, Gaetano Rocco, and Francesco Perrone, Istituto Nazionale Tumori-Fondazione "G. Pascale" Istituto di Ricovero e Cura a Carattere Scientifico; Ciro Gallo, Fortunato Ciardiello, and Simona Signoriello, Second University; Sabino De Placido, Federico II University, Napoli; Cesare Gridelli, S.G. Moscati Hospital, Avellino; Vittorio Gebbia, Istituto La Maddalena, Palermo; Anna Ceribelli, Regina Elena National Cancer Institute, Roma; Adolfo G. Favaretto, Istituto Oncologico Veneto, Padova, Italy; Natasha B. Leighl and Ronald Feld, Princess Margaret Hospital/University Health Network, Toronto; and Charles Butts, Cross Cancer Institute, Edmonton, Alberta, Canada.

Published: March 2015

Purpose: Information about symptomatic toxicities of anticancer treatments is not based on direct report by patients, but rather on reports by clinicians in trials. Given the potential for under-reporting, our aim was to compare reporting by patients and physicians of six toxicities (anorexia, nausea, vomiting, constipation, diarrhea, and hair loss) within three randomized trials.

Patients And Methods: In one trial, elderly patients with breast cancer received adjuvant chemotherapy; in two trials, patients with advanced non-small-cell lung cancer received first-line treatment. Toxicity was prospectively collected by investigators (graded by National Cancer Institute Common Toxicity Criteria [version 2.0] or Common Terminology Criteria for Adverse Events [version 3]). At the end of each cycle, patients completed the European Organisation for Research and Treatment of Cancer quality-of-life questionnaires, including toxicity-related symptom items. Possible answers were "not at all," "a little," "quite a bit," and "very much." Analysis was limited to the first three cycles. For each toxicity, agreement between patients and physicians and under-reporting by physicians (ie, toxicity reported by patients but not reported by physicians) were calculated.

Results: Overall, 1,090 patients (2,482 cycles) were included. Agreement between patients and physicians was low for all toxicities. Toxicity rates reported by physicians were always lower than those reported by patients. For patients who reported toxicity (any severity), under-reporting by physicians ranged from 40.7% to 74.4%. Examining only patients who reported "very much" toxicity, under-reporting by physicians ranged from 13.0% to 50.0%.

Conclusion: Subjective toxicities are at high risk of under-reporting by physicians, even when prospectively collected within randomized trials. This strongly supports the incorporation of patient-reported outcomes into toxicity reporting in clinical trials.

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.9334DOI Listing

Publication Analysis

Top Keywords

under-reporting physicians
16
patients
12
patients physicians
12
patients reported
12
physicians
9
symptomatic toxicities
8
three randomized
8
randomized trials
8
cancer received
8
toxicity
8

Similar Publications

Article Synopsis
  • A systematic review was conducted to examine patient-centred handover in healthcare, highlighting the importance of including patients or carers in the process.
  • The study analyzed 30 peer-reviewed articles, predominantly focused on nursing-led bedside handover, showing benefits like increased patient satisfaction and engagement, but also noted challenges such as cognitive load and compliance issues.
  • While patient-centred handover appears beneficial, potential advantages may be overshadowed by barriers and varying outcomes, particularly with limited studies on physician-led handovers involving patients.
View Article and Find Full Text PDF

Unveiling the Gaps: Analyzing Family Physicians' Perspectives on Infectious Disease Notification in Türkiye.

J Public Health Manag Pract

October 2024

Author Affiliations: Department of Public Health, Medical Faculty, Pamukkale University, Denizli, Turkey (Dr Uzun); Department of Public Health, Medical Faculty, Ankara University, Ankara, Turkey (Dr Usturali Mut), and Yenimahalle Gazi Family Health Centre, Ankara, Turkey (Dr Mut).

Objective: This study aimed to assess the opinions, attitudes, and behaviors of family physicians in Türkiye regarding mandatory communicable disease notification.

Design: Cross-sectional study.

Setting: A national online survey in Türkiye.

View Article and Find Full Text PDF

Development of an Expert-Based Scoring System for Early Identification of Patients with Inborn Errors of Immunity in Primary Care Settings - the PIDCAP Project.

J Clin Immunol

October 2024

Infection and Immunity in Pediatric Patients Research Group, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Catalonia, Spain.

Article Synopsis
  • Early diagnosis of inborn errors of immunity (IEIs) can significantly reduce mortality, morbidity, and healthcare costs, highlighting the importance of early identification and intervention.
  • A new computer-based tool, developed with expert input, provides primary care physicians with a set of warning signs to assist in diagnosing IEIs more effectively in both pediatric and adult patients.
  • The PIDCAP tool, featuring a scoring system based on 27 warning signs for children and 24 for adults, aims to enhance early detection of IEIs and has been successfully tested for feasibility in primary care settings, offering a potential solution to reduce diagnostic delays.
View Article and Find Full Text PDF
Article Synopsis
  • The study looked into whether patients change their answers on surveys about their health when they know doctors will read them.
  • Researchers compared two groups of patients: one that knew their answers would be seen by doctors and another that didn't.
  • The results showed no big differences in answers between the two groups, suggesting it's okay for doctors to use these surveys to help understand patients' needs.
View Article and Find Full Text PDF

Falls in older adults and those with neurodegenerative disease (ND) are a current public health hazard and the primary cause of sustaining a mild traumatic brain injury (mTBI)/concussion. Little is known regarding how post-concussion symptoms present in older adults and patients with ND, even though they are the demographic at highest risk. A combination of under-reporting of falls and a lack of awareness regarding potential consequences of falls, results in the underdiagnosis of post-fall issues and concussions in this population.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!